AU2003301900A1 - Antipruritic drug - Google Patents

Antipruritic drug

Info

Publication number
AU2003301900A1
AU2003301900A1 AU2003301900A AU2003301900A AU2003301900A1 AU 2003301900 A1 AU2003301900 A1 AU 2003301900A1 AU 2003301900 A AU2003301900 A AU 2003301900A AU 2003301900 A AU2003301900 A AU 2003301900A AU 2003301900 A1 AU2003301900 A1 AU 2003301900A1
Authority
AU
Australia
Prior art keywords
antipruritic drug
antipruritic
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003301900A
Inventor
Iwao Arai
Fumie Sato
Norikazu Takano
Tohru Tanami
Makoto Yagi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of AU2003301900A1 publication Critical patent/AU2003301900A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/559—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing hetero atoms other than oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
AU2003301900A 2002-11-13 2003-11-13 Antipruritic drug Abandoned AU2003301900A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002329980 2002-11-13
JP2002-329980 2002-11-13
PCT/JP2003/014446 WO2004043471A1 (en) 2002-11-13 2003-11-13 Antipruritic drug

Publications (1)

Publication Number Publication Date
AU2003301900A1 true AU2003301900A1 (en) 2004-06-03

Family

ID=32310586

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003301900A Abandoned AU2003301900A1 (en) 2002-11-13 2003-11-13 Antipruritic drug

Country Status (3)

Country Link
JP (1) JP4477504B2 (en)
AU (1) AU2003301900A1 (en)
WO (1) WO2004043471A1 (en)

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3126924A1 (en) * 1981-07-03 1983-01-20 Schering Ag, 1000 Berlin Und 4619 Bergkamen 9-FLUOR PROSTAGLAND DERIVATIVES, METHOD FOR THE PRODUCTION AND USE AS A MEDICINAL PRODUCT
DE3325175A1 (en) * 1983-07-08 1985-01-17 Schering AG, 1000 Berlin und 4709 Bergkamen 11-HALOGEN PROSTANE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICINAL PRODUCTS
DE3347128A1 (en) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen 9-HALOGEN- (DELTA) (ARROW HIGH) 2 (ARROW HIGH) -PROSTAGLAND IN DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICINAL PRODUCTS
EP0299914B2 (en) * 1987-07-17 2003-04-23 Schering Aktiengesellschaft 9-Halogen (Z) prostaglandin derivatives, process for their production and their use as medicines
KR100266834B1 (en) * 1992-07-24 2000-09-15 우에하라 아끼라 Prostaglandin derivative
EP0666256A1 (en) * 1992-10-20 1995-08-09 Taisho Pharmaceutical Co. Ltd Prostaglandine derivative
US6124344A (en) * 1993-12-28 2000-09-26 Allergan Sales, Inc. Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
JP3579448B2 (en) * 1993-12-29 2004-10-20 大正製薬株式会社 Prostaglandin derivatives, salts thereof and uses thereof
JP3573482B2 (en) * 1994-03-07 2004-10-06 大正製薬株式会社 Prostaglandin derivatives and uses thereof
JP3506485B2 (en) * 1994-04-19 2004-03-15 大正製薬株式会社 Prostaglandin derivatives
US5807892A (en) * 1994-09-30 1998-09-15 Alcon Laboratories, Inc. Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
WO1996016935A1 (en) * 1994-11-30 1996-06-06 Taisho Pharmaceutical Co., Ltd. Prostaglandin derivative
JPH09286775A (en) * 1996-04-24 1997-11-04 Taisho Pharmaceut Co Ltd Prostaglandin derivative
ES2259806T5 (en) * 1996-12-23 2009-05-01 S.L.A. Pharma Ag PHARMACEUTICAL COMPOSITION TO TREAT FECAL INCONTINENCE.
NO317155B1 (en) * 1997-02-04 2004-08-30 Ono Pharmaceutical Co <Omega> -cycloalkyl-prostaglandin-E <N> 2 </ N> derivatives
ES2211083T3 (en) * 1998-05-25 2004-07-01 Taisho Pharmaceutical Co., Ltd DERIVATIVE OF PROSTAGLANDINA.
TWI249520B (en) * 1998-07-15 2006-02-21 Ono Pharmaceutical Co 5-Thia-omega-substituted phenyl prostaglandin E derivatives, method for producing the same and medicines containing the same as the active ingredient
JP2000273083A (en) * 1999-03-19 2000-10-03 Taisho Pharmaceut Co Ltd Prostaglandin derivative
JP2001089443A (en) * 1999-07-19 2001-04-03 Taisho Pharmaceut Co Ltd Prostaglandin derivative
AU766983B2 (en) * 1999-09-10 2003-10-30 Fumie Sato Prostaglandin derivatives
JP2001122786A (en) * 1999-10-20 2001-05-08 Taisho Pharmaceut Co Ltd Sleep-inducing agent
JP2001151749A (en) * 1999-11-24 2001-06-05 Taisho Pharmaceut Co Ltd Prostaglandin derivative
KR20020067594A (en) * 2000-01-05 2002-08-22 오노 야꾸힝 고교 가부시키가이샤 5-THIA-ω-(SUBSTITUTED PHENYL)-PROSTAGLANDINE E ALCOHOLS,PROCESS FOR PREPARING THE ALCOHOLS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME AS THE ACTIVE INGREDIENT
AU2001278771A1 (en) * 2000-08-22 2002-03-04 Ono Pharmaceutical Co. Ltd. Carboxylic acid derivatives, process for producing the same and drugs containingthe same as the active ingredient
CA2419722A1 (en) * 2000-09-01 2003-02-21 Masaki Asada Benzoic acid derivatives and drugs containing the same as the active ingredient
AU2003207102C1 (en) * 2002-02-22 2008-02-21 Fumie Sato Antipruritics
TWI274055B (en) * 2002-08-09 2007-02-21 Taisho Pharmaceutical Co Ltd Aryl-5-thio-beta-D-glucopyranoside derivatives and remedies for diabetes containing the same

Also Published As

Publication number Publication date
JPWO2004043471A1 (en) 2006-03-09
WO2004043471A1 (en) 2004-05-27
JP4477504B2 (en) 2010-06-09

Similar Documents

Publication Publication Date Title
AU2002335152A1 (en) Robot-phone
AU2003215209A1 (en) Syringe
AU2003259457A1 (en) Auto-destructible syringe
AU2002367810A1 (en) Bis-transition-metal-chelate-probes
AU2002368348A1 (en) Electrosomatogram
AU2002348964A1 (en) Snowbike
AU2002341221A1 (en) Honey-brandy
AU2003301900A1 (en) Antipruritic drug
AU2003268985A1 (en) Cannula
AU2002344387A1 (en) Multifunction-pillow
AU2003244272A1 (en) Segment
AU2002100508A4 (en) Photocard
AU2002100482A4 (en) Tail-gate-ezy
AU2002100160A4 (en) Oxidirator
AU2002100031A4 (en) earliPay
AU2002100747A4 (en) Powersell
AU2002100026A4 (en) Disc400
AU2002100498A4 (en) Linline
AU2002100957A4 (en) Sluggit
AU2002100739A4 (en) Neuramax
AU2002100602A4 (en) Bonsystem
AU2002100468A4 (en) Flexi-edger
AU2002100541A4 (en) Backmate
AU2002100280A4 (en) Proshoe
AU2002100510A4 (en) Bottlenecker

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase